Skip to content

Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers.

Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers : a Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03698656
Acronym
SPIEVIE
Enrollment
40
Registered
2018-10-09
Start date
2018-10-10
Completion date
2020-10-01
Last updated
2020-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Leukemia, Lymphoma

Keywords

Spiritual dimension, Hematologic cancer, Acute leukemia, Lymphoma, Nurse interview, Quality of life

Brief summary

Pilot study on feasibility of taking into account spiritual dimension in nurse's care of patients with haematologic cancer

Detailed description

Patients with acute leukaemia or lymphoma will be invited to have three interviews centered on spiritual issues on a six-eight months period. The intervention consist on 3 intervention interviews conducted at the beginning of the study and approximatively 2 and 4 months later (according to the program of medical care). Quality of life (FACT-G) and spiritual well-being (FACIT-SP12) scales will be completed at the beginning (before the first intervention interview) and at the end of the study (approximately 2 month after the third intervention interview, i.e. 6 to 8 month after the first interview). This pilot study will assess the proportion of patients who will accept to enter in the study and to complete it.

Interventions

BEHAVIORALSpiritual Interview

Three patient interviews (45 to 60 minutes) will be conducted by the study nurse at the beginning of the study and approximately 2 and 4 month later, according to the program of the medical care. Each interview will be conducted according the active listening method of Carl Rogers.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with acute leukaemia or lymphoma, in the first month of hospitalisation after primary diagnosis or firs relapse * More than 17 years old * French language * Having signed informed consent

Exclusion criteria

* Patients requiring palliative care * Important psychic vulnerability or severe psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Rate of patients accepting to enter the study and to complete it on the 6 - 8 month period6-8 monthsNumber of patients having entered the study with regards to the number of the contacted patients, and number of patients having completed the six-eight month study with regards to the patients having entered the study

Secondary

MeasureTime frameDescription
Rate of entire completion of quality of life scales6-8 monthsRate of entire completion of functional assessment of cancer therapy - general and The Functional Assessment of Chronic Illness Therapy Spiritual Well-Being 12 items scales whose values will be used in order to determine the sample size of a further randomised controlled trial
Number of contacted patients with regards to the number of eligible hospitalized patients6-8 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026